Genesystem Co., Ltd. (KOSDAQ: A363250)
Health Care · Biotechnology · KR
₩4,145.00
+1.97% today · -33.1% 1Y
Genesystem Co., Ltd. (KOSDAQ: A363250) operates in the Biotechnology industry within the Health Care sector. The company is valued at $25.76M.
Over the last twelve months the share price has lost 33.1%, trading between 2.85K and 7.26K.
Tweenvest scores Genesystem Co., Ltd. across four factors: quality 49/100, value 46/100. Its strongest factor is quality.
A363250 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.76M
- Revenue (TTM)
- $652.21K
- P/E
- —
- EPS
- -1,418.79
- Dividend yield
- —
- Beta (5Y)
- -0.09
- 52-week high
- ₩7,260.00
- 52-week low
- ₩2,850.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.29M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Isofol Medical AB (publ)OM: ISOFOL | $26.73M | Skr0.83 | +3.51% |
| Kim Forest Enterprise Co., Ltd.TWSE: 6645 | $26.71M | NT$14.35 | +6.30% |
| Noile-Immune Biotech Inc.TSE: 4893 | $25.84M | ¥94.00 | -7.84% |
| Seoulin Bioscience Co.,Ltd.KOSDAQ: A038070 | $25.81M | ₩3,810.00 | -6.39% |
| Kainos Medicine, Inc.KOSDAQ: A284620 | $25.58M | ₩— | — |
| D. Western Therapeutics Institute, Inc.TSE: 4576 | $25.15M | ¥69.00 | -1.43% |
| Immutep LimitedASX: IMM | $24.85M | AU$0.02 | +4.35% |
| Genvor IncorporatedOTCPK: GNVR | $24.85M | $0.68 | -24.17% |
Figures last refreshed Oct 18, 2026.